MedPath

Protein for Premies

Not Applicable
Completed
Conditions
Extreme Prematurity
Registration Number
NCT01773902
Lead Sponsor
University Hospital Tuebingen
Brief Summary

Although expressed breast milk is considered the optimal nutritional source for preterm infants, the macronutrient content is insufficient to enable optimal growth during neonatal intensive care. Optimal dose and optimal mode of administration (standardized or individualized) of enteral protein supplementation to very preterm infants have not been established.

This study aims to compare the effects on weight gain of different modes of enteral protein supplementation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • very preterm infants <32 weeks gestation and <1500g birth weight
  • > 100ml/kg/d of enteral feeding
Exclusion Criteria
  • missing informed consent
  • decision not to feed breast milk
  • congenital malformations
  • age > 7 days at study entry

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Weight gainFrom birth - to the end of study intervention (anticipated to be on average 1 week before discharge home at approx 37 weeks PMA)
Secondary Outcome Measures
NameTimeMethod
Head circumference growthFrom birth - to the end of study intervention (anticipated to be on average 1 week before discharge home at approx 37 weeks PMA)

Trial Locations

Locations (1)

University Children's Hospital Tuebingen

🇩🇪

Tuebingen, Germany

University Children's Hospital Tuebingen
🇩🇪Tuebingen, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.